175 related articles for article (PubMed ID: 16378833)
1. Increase in platelet non-integrin type I collagen receptor in patients with systemic sclerosis.
Chiang TM; Takayama H; Postlethwaite AE
Thromb Res; 2006; 117(3):299-306. PubMed ID: 16378833
[TBL] [Abstract][Full Text] [Related]
2. Collagen-type specificity of glycoprotein VI as a determinant of platelet adhesion.
Jung SM; Takemura Y; Imamura Y; Hayashi T; Adachi E; Moroi M
Platelets; 2008 Feb; 19(1):32-42. PubMed ID: 18231936
[TBL] [Abstract][Full Text] [Related]
3. Alteration in protein kinase B (AKT) activity in platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Thromb Res; 2008; 122(4):501-6. PubMed ID: 18355897
[TBL] [Abstract][Full Text] [Related]
4. Neuron specific enolase concentration is increased in serum and decreased in platelets of patients with active systemic sclerosis.
Massabki PS; Silva NP; Lourenço DM; Andrade LE
J Rheumatol; 2003 Dec; 30(12):2606-12. PubMed ID: 14719201
[TBL] [Abstract][Full Text] [Related]
5. The S1P(2) receptor expressed in human platelets is linked to the RhoA-Rho kinase pathway and is down regulated in type 2 diabetes.
Randriamboavonjy V; Badenhoop K; Schmidt H; Geisslinger G; Fisslthaler B; Fleming I
Basic Res Cardiol; 2009 May; 104(3):333-40. PubMed ID: 19139947
[TBL] [Abstract][Full Text] [Related]
6. Platelet receptors for collagen.
Moroi M; Jung SM
Thromb Haemost; 1997 Jul; 78(1):439-44. PubMed ID: 9198193
[TBL] [Abstract][Full Text] [Related]
7. Type I and type III collagen-platelet interaction: inhibition by type specific receptor peptides.
Zhu J; Cole F; Woo-Rasberry V; Fang XR; Chiang TM
Thromb Res; 2007; 119(1):111-9. PubMed ID: 16472843
[TBL] [Abstract][Full Text] [Related]
8. Critical roles for the actin cytoskeleton and cdc42 in regulating platelet integrin alpha2beta1.
Pula G; Poole AW
Platelets; 2008 May; 19(3):199-210. PubMed ID: 18432521
[TBL] [Abstract][Full Text] [Related]
9. Increased circulating concentrations of the counteradhesive proteins SPARC and thrombospondin-1 in systemic sclerosis (scleroderma). Relationship to platelet and endothelial cell activation.
Macko RF; Gelber AC; Young BA; Lowitt MH; White B; Wigley FM; Goldblum SE
J Rheumatol; 2002 Dec; 29(12):2565-70. PubMed ID: 12465153
[TBL] [Abstract][Full Text] [Related]
10. Antibody against platelet membrane glycoprotein VI in a patient with systemic lupus erythematosus.
Takahashi H; Moroi M
Am J Hematol; 2001 Aug; 67(4):262-7. PubMed ID: 11443641
[TBL] [Abstract][Full Text] [Related]
11. A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
York MR; Nagai T; Mangini AJ; Lemaire R; van Seventer JM; Lafyatis R
Arthritis Rheum; 2007 Mar; 56(3):1010-20. PubMed ID: 17328080
[TBL] [Abstract][Full Text] [Related]
12. Platelet contributions to the pathogenesis of systemic sclerosis.
Postlethwaite AE; Chiang TM
Curr Opin Rheumatol; 2007 Nov; 19(6):574-9. PubMed ID: 17917538
[TBL] [Abstract][Full Text] [Related]
13. Anti-glycoprotein VI monoclonal antibodies directly aggregate platelets independently of FcgammaRIIa and induce GPVI ectodomain shedding.
Al-Tamimi M; Mu FT; Arthur JF; Shen Y; Moroi M; Berndt MC; Andrews RK; Gardiner EE
Platelets; 2009 Mar; 20(2):75-82. PubMed ID: 19235048
[TBL] [Abstract][Full Text] [Related]
14. [Collagen adhesion-aggregation abnormality (2nd report)--congenital platelet membrane glycoprotein VI deficiency].
Shinmyozu K; Kuriyama M; Okadome T; Maruyama Y; Maruyama I; Osame M
Rinsho Ketsueki; 1990 May; 31(5):660-4. PubMed ID: 2168494
[TBL] [Abstract][Full Text] [Related]
15. Effect of nitric oxide and peroxynitrite on type I collagen synthesis in normal and scleroderma dermal fibroblasts.
Dooley A; Gao B; Shi-Wen X; Abraham DJ; Black CM; Jacobs M; Bruckdorfer KR
Free Radic Biol Med; 2007 Jul; 43(2):253-64. PubMed ID: 17603934
[TBL] [Abstract][Full Text] [Related]
16. Increase in phosphotidylinositide-3 kinase activity by nitrotyrosylation of lysates of platelets from patients with systemic sclerosis.
Chiang TM; Postlethwaite AE
Biochim Biophys Acta; 2006 Jan; 1760(1):32-7. PubMed ID: 16271833
[TBL] [Abstract][Full Text] [Related]
17. Vascular damage and lack of angiogenesis in systemic sclerosis skin.
Konttinen YT; Mackiewicz Z; Ruuttila P; Ceponis A; Sukura A; Povilenaite D; Hukkanen M; Virtanen I
Clin Rheumatol; 2003 Sep; 22(3):196-202. PubMed ID: 14505210
[TBL] [Abstract][Full Text] [Related]
18. No evidence for systemic platelet activation during or after orthotopic liver transplantation.
Pereboom IT; Adelmeijer J; van Leeuwen Y; Hendriks HG; Porte RJ; Lisman T
Liver Transpl; 2009 Aug; 15(8):956-62. PubMed ID: 19642138
[TBL] [Abstract][Full Text] [Related]
19. Platelet activation, endothelial cell dysfunction in the absence of anticardiolipin antibodies in systemic sclerosis.
Lima J; Fonollosa V; Fernández-Cortijo J; Ordi J; Cuenca R; Khamashta MA; Vilardell M; Simeón CP; Picó M
J Rheumatol; 1991 Dec; 18(12):1833-6. PubMed ID: 1839040
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of transforming growth factor beta receptor type I and up-regulation of matrix gene program: A model of scleroderma.
Pannu J; Gardner H; Shearstone JR; Smith E; Trojanowska M
Arthritis Rheum; 2006 Sep; 54(9):3011-21. PubMed ID: 16947635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
